Effects of type 5-phosphodiesterase inhibition on energy metabolism and mitochondrial biogenesis in human adipose tissue ex vivo

Mitochondrial formation of reactive oxygen species

Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · see citing works

Fat and Beyond: The Diverse Biology of PPARγ

Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · see citing works

Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide

Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243 · see citing works

The role of mitochondria in the pathogenesis of type 2 diabetes

Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551 · see citing works

Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function

Rybalkin, S. D., Chen, Y., Bornfeldt, K., & Beavo, J. A. (2003) · Circulation Research · doi:10.1161/01.res.0000087541.15600.2b · Cited by 511 · see citing works

Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals

Nisoli, E., Falcone, S., Tonello, C., Cozzi, V., Palomba, L., Fiorani, M., Pisconti, A., Brunelli, S., Cardile, A., Francolini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405432101 · Cited by 495 · see citing works

Mitochondria are impaired in the adipocytes of type 2 diabetic mice.

Choo, H.-J., Kim, J.-H., Kwon, O.-B., Lee, C. S., Mun, J. Y., Han, S. S., Yoon, Y.-S., Yoon, G., Choi, K.-M., & Ko, Y.-G. (2006) · Diabetologia · doi:10.1007/s00125-006-0170-2 · Cited by 365 · see citing works

Protective vascular and myocardial effects of adiponectin

Goldstein, B. J., Scalia, R. G., & Ma, X. L. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1398 · Cited by 288 · see citing works

Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity

Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., Yamahara, K., Taura, D., Inuzuka, M., Sonoyama, T., et al. (2009) · Diabetes · doi:10.2337/db09-0393 · Cited by 288 · see citing works

The metabolic consequences of childhood obesity

Weiss, R., & Caprio, S. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.04.009 · Cited by 278 · see citing works

Essential role of mitochondrial function in adiponectin synthesis in adipocytes

Koh, E. H., Park, J.-Y., Park, H.-S., Jeon, M. J., Ryu, J. W., Kim, M., Kim, S. Y., Kim, M.-S., Kim, S.-W., Park, I. S., et al. (2007) · Diabetes · doi:10.2337/db07-0510 · Cited by 275 · see citing works

Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells

Selemidis, S., Dusting, G. J., Peshavariya, H., Kemp‐Harper, B. K., & Drummond, G. R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.030 · Cited by 221 · see citing works

Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes

Tedesco, L., Valerio, A., Cervino, C., Cardile, A., Pagano, C., Vettor, R., Pasquali, R., Carruba, M. O., Marsicano, G., Lutz, B., et al. (2008) · Diabetes · doi:10.2337/db07-1623 · Cited by 145 · see citing works

Regulation of the nitric oxide system in human adipose tissue

Engeli, S., Janke, J., Gorzelniak, K., Böhnke, J., Ghose, N., Lindschau, C., Luft, F. C., & Sharma, A. M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300322-jlr200 · Cited by 123 · see citing works

Inhibition of mitochondrial fission favours mutant over wild-type mitochondrial DNA

Malena, A., Loro, E., Di Re, M., Holt, I. J., & Vergani, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp281 · Cited by 107 · see citing works

Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man

Enoksson, S., Degerman, E., Toft, E., Large, V., & Arner, P. (1998) · Diabetologia · doi:10.1007/s001250050947 · Cited by 88 · see citing works

Nitroaspirins and Morpholinosydnonimine but Not Aspirin Inhibit the Formation of Superoxide and the Expression of gp91 phox Induced by Endotoxin and Cytokines in Pig Pulmonary Artery Vascular Smooth Muscle Cells and Endothelial Cells

Muzaffar, S., Shukla, N., Angelini, G. D., & Jeremy, J. Y. (2004) · Circulation · doi:10.1161/01.cir.0000139851.50067.e4 · Cited by 75 · see citing works

Cell cycle-dependent mitochondrial biogenesis and dynamics in mammalian cells

Lee, S.-M., Kim, S., Sun, X., Lee, J. H., & Cho, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.091 · Cited by 71 · see citing works

Sildenafil promotes adipogenesis through a PKG pathway

Zhang, X., Ji, J., Yan, G., Wu, J., Sun, X., Shen, J., Jiang, H., & Wang, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.064 · Cited by 63 · see citing works

eNOS plays a major role in adiponectin synthesis in adipocytes

Koh, E. H., Kim, M. K., Ranjan, K. C., Kim, H. S., Park, H., Oh, K. S., Park, I.-S., Lee, W. J., Kim, M., Park, J., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2010 · Cited by 51 · see citing works

Phosphodiesterase‐5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide‐mediated lipolysis

Moro, C., Klimčáková, E., Lafontan, M., Berlan, M., & Galitzky, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707485 · Cited by 49 · see citing works

Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart

Foresta, C., Caretta, N., Corona, G., Fabbri, A., Francavilla, S., Jannini, E. A., Maggi, M., Bettocchi, C., & Lenzi, A. (2008) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00932.x · Cited by 49 · see citing works

Control of mitochondrial biogenesis, ROS level, and cytosolic Ca2+ concentration during the cell cycle and the onset of differentiation in L6E9 myoblasts

Jahnke, V. E., Sabido, O., & Freyssenet, D. G. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00377.2008 · Cited by 45 · see citing works

Critical Amino Acids in Phosphodiesterase-5 Catalytic Site That Provide for High-Affinity Interaction with Cyclic Guanosine Monophosphate and Inhibitors

Zoraghi, R., Francis, S. H., & Corbin, J. D. (2007) · Biochemistry · doi:10.1021/bi7010702 · Cited by 36 · see citing works

Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes

Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 810 · see citing works

Mitochondria as a Therapeutic Target in Heart Failure

Bayeva, M., Gheorghiade, M., & Ardehali, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 336 · see citing works

Regulation of obesity and insulin resistance by nitric oxide

Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274 · see citing works

Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases

Whitaker, R. M., Corum, D. G., Beeson, C., & Schnellmann, R. G. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103155 · Cited by 200 · see citing works

cGMP-Selective Phosphodiesterase Inhibitors Stimulate Mitochondrial Biogenesis and Promote Recovery from Acute Kidney Injury

Whitaker, R. M., Wills, L. P., Stallons, L. J., & Schnellmann, R. G. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208017 · Cited by 92 · see citing works

Obesity and Erectile Dysfunction: From Bench to Clinical Implication

Moon, K. H., Park, S., & Kim, Y.-W. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180026 · Cited by 92 · see citing works

Synergistic Effects of Polyphenols and Methylxanthines with Leucine on AMPK/Sirtuin-Mediated Metabolism in Muscle Cells and Adipocytes

Bruckbauer, A., & Zemel, M. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089166 · Cited by 82 · see citing works

Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases

Cameron, R. B., Beeson, C. C., & Schnellmann, R. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00669 · Cited by 74 · see citing works

Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension

Chrysant, S. G. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0377-9 · Cited by 61 · see citing works

Sildenafil induces browning of subcutaneous white adipose tissue in overweight adults

Li, S., Li, Y., Xiang, L., Dong, J., Liu, M., & Xiang, G. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.008 · Cited by 55 · see citing works

A compendium of G-protein–coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure

Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 51 · see citing works

UCP1 activation: Hottest target in the thermogenesis pathway to treat obesity using molecules of synthetic and natural origin

Jagtap, U. A., & Paul, A. T. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103717 · Cited by 43 · see citing works

Targeting adipose tissue

Haas, B., Schlinkert, P., Mayer, P. E., & Eckstein, N. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-43 · Cited by 42 · see citing works

Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors

Masadeh, M. M., Alzoubi, K. H., Khabour, O. F., & Al-Azzam, S. I. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.11.001 · Cited by 41 · see citing works

cGMP and Brown Adipose Tissue

Hoffmann, L. S., Larson, C. J., & Pfeifer, A. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_3 · Cited by 28 · see citing works

Antiobesogenic Role of Endothelial Nitric Oxide Synthase

Sansbury, B. E., & Hill, B. G. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00013-1 · Cited by 25 · see citing works

Non-Sexual Implications of Phosphodiesterase Type 5 Inhibitors

Mostafa, T. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.02.004 · Cited by 18 · see citing works

Phosphodiesterase 5 as target for adipose tissue disorders

Colombo, G., Colombo, M. D. H. P., Schiavon, L. D. L., & d'Acâmpora, A. J. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.10.006 · Cited by 13 · see citing works

PDE5 inhibitor protects the mitochondrial function of hypoxic myocardial cells

Jia, H., Guo, Z., & Yao, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6951 · Cited by 13 · see citing works

Obesity and Erectile Dysfunction: From Bench to Clinical Implication

Moon, K. H., Park, S., & Kim, Y.-W. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.wjmh.180026 · Cited by 12 · see citing works

Rescue of Heart Failure by Mitochondrial Recovery

Marquez, J. C., Lee, S. R., Kim, N., & Han, J. (2006) · International Neurourology Journal · doi:10.5213/inj.1632570.285 · Cited by 12 · see citing works

Acute effects of physical exercise and phosphodiesterase’s type 5 inhibition on serum 11β-hydroxysteroid dehydrogenases related glucocorticoids metabolites: a pilot study

Di Luigi, L., Botrè, F., Sabatini, S., Sansone, M., Mazzarino, M., Guidetti, L., Baldari, C., Lenzi, A., Caporossi, D., Romanelli, F., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0185-2 · Cited by 11 · see citing works

Pharmacological Activation of Mitochondrial Biogenesis for the Treatment of Various Pathologies

Gibbs, W. S., Scholpa, N. E., Beeson, C. C., & Schnellmann, R. G. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch39 · Cited by 4 · see citing works

The anti-obesogenic effects of nitric oxide.

Sansbury, B. E. (2014) · doi:10.18297/etd/1262

A hipertóniától a szívelégtelenségig

Magyar, K., Deres, L., Gál, R., Riba, Á., Habon, T., Tóth, K., & Halmosi, R. (2017) · Cardiologia Hungarica · doi:10.26430/chungarica.2017.47.2.139

Phosphodiesterase 5 as target for adipose tissue disorders

Colombo, G., Colombo, M. D. H. P., Schiavon, L. D. L., & d'Acâmpora, A. J. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.10.006 · Cited by 13 · see citing works

PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes

Yu, H. M., Chung, H. K., Kim, K. S., Lee, J. M., Hong, J. H., & Park, K. S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.140 · Cited by 14 · see citing works

Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?

Armani, A., Marzolla, V., Rosano, G. M. C., Fabbri, A., & Caprio, M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.004 · Cited by 54 · see citing works

Pde5a deficiency prevents diet-induced obesity via adipose cAMP-PKA activation enhancing fat browning

Campolo, F., Giampaoli, O., Barbagallo, F., Palmisano, B., Maio, A. D., Sciarra, F., Rizzo, F., Monti, S., Albanese, S., Cardarelli, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102243 · Cited by 5 · see citing works

Chronic phosphodiesterase type 5 inhibition has beneficial effects on subcutaneous adipose tissue plasticity in type 2 diabetic mice

Fiore, D., Gianfrilli, D., Cardarelli, S., Naro, F., Lenzi, A., Isidori, A. M., & Venneri, M. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26796 · Cited by 9 · see citing works